Patient Diversity in Global Industry Clinical Trials: Why It Matters, Who Should Be Concerned, and What Can Be Done?
<p id="p1">In their recent guidance to the industry the US FDA stated that it is concerned proposed the industry is rightfully concerned about patient diversity in industry-sponsored clinical trials (iCTs) due to a lack of attention on enrollment of representative numbers of participants from underr...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1121596 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|